Mission Therapeutics appoints Colin Goddard to board
This article was originally published in Scrip
Mission Therapeutics, a drug discovery and development company, has named Dr Colin Goddard, former CEO of OSI Pharmaceuticals, to its board of directors. Dr Goddard joined OSI as a research scientist in 1989 and led the transformation of the technology platform services company into a profitable fully integrated biopharmaceutical organization, becoming CEO in 1998. OSI was acquired by Astellas Pharma in June 2010 for $4bn.